vs

Side-by-side financial comparison of WARRIOR MET COAL, INC. (HCC) and Indivior Pharmaceuticals, Inc. (INDV). Click either name above to swap in a different company.

WARRIOR MET COAL, INC. is the larger business by last-quarter revenue ($384.0M vs $357.0M, roughly 1.1× Indivior Pharmaceuticals, Inc.). Indivior Pharmaceuticals, Inc. runs the higher net margin — 28.9% vs 6.0%, a 22.9% gap on every dollar of revenue.

Warrior Met Coal, Inc. (ticker HCC) is a U.S.-headquartered mining enterprise that produces and distributes high-grade metallurgical coal, a key raw material for steel production. It serves steel manufacturers and industrial clients across core markets including North America, Europe, and Asia.

Indivior is a global specialty pharmaceutical company dedicated to developing and commercializing evidence-based treatments for substance use disorders such as opioid use disorder and alcohol dependence, as well as related mental health conditions. Its primary operating markets are North America and Europe, with a portfolio of approved therapies targeting unmet medical needs for underserved patient groups.

HCC vs INDV — Head-to-Head

Bigger by revenue
HCC
HCC
1.1× larger
HCC
$384.0M
$357.0M
INDV
Higher net margin
INDV
INDV
22.9% more per $
INDV
28.9%
6.0%
HCC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCC
HCC
INDV
INDV
Revenue
$384.0M
$357.0M
Net Profit
$23.0M
$103.0M
Gross Margin
29.5%
82.1%
Operating Margin
9.0%
22.7%
Net Margin
6.0%
28.9%
Revenue YoY
29.1%
Net Profit YoY
1919.5%
390.5%
EPS (diluted)
$0.43
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCC
HCC
INDV
INDV
Q4 25
$384.0M
$357.0M
Q3 25
$328.6M
$314.0M
Q2 25
$297.5M
$302.0M
Q1 25
$299.9M
$266.0M
Q4 24
$297.5M
Q3 24
$327.7M
$307.0M
Q2 24
$396.5M
$299.0M
Q1 24
$503.5M
Net Profit
HCC
HCC
INDV
INDV
Q4 25
$23.0M
$103.0M
Q3 25
$36.6M
$42.0M
Q2 25
$5.6M
$18.0M
Q1 25
$-8.2M
$47.0M
Q4 24
$1.1M
Q3 24
$41.8M
$22.0M
Q2 24
$70.7M
$-97.0M
Q1 24
$137.0M
Gross Margin
HCC
HCC
INDV
INDV
Q4 25
29.5%
82.1%
Q3 25
27.1%
73.2%
Q2 25
23.9%
82.8%
Q1 25
18.1%
83.1%
Q4 24
23.1%
Q3 24
29.3%
78.5%
Q2 24
34.1%
73.6%
Q1 24
43.3%
Operating Margin
HCC
HCC
INDV
INDV
Q4 25
9.0%
22.7%
Q3 25
6.3%
13.7%
Q2 25
2.6%
23.8%
Q1 25
-5.8%
24.8%
Q4 24
-1.4%
Q3 24
11.9%
11.4%
Q2 24
17.9%
-39.5%
Q1 24
29.6%
Net Margin
HCC
HCC
INDV
INDV
Q4 25
6.0%
28.9%
Q3 25
11.1%
13.4%
Q2 25
1.9%
6.0%
Q1 25
-2.7%
17.7%
Q4 24
0.4%
Q3 24
12.7%
7.2%
Q2 24
17.8%
-32.4%
Q1 24
27.2%
EPS (diluted)
HCC
HCC
INDV
INDV
Q4 25
$0.43
$0.79
Q3 25
$0.70
$0.33
Q2 25
$0.11
$0.14
Q1 25
$-0.16
$0.38
Q4 24
$0.02
Q3 24
$0.80
$0.16
Q2 24
$1.35
$-0.72
Q1 24
$2.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCC
HCC
INDV
INDV
Cash + ST InvestmentsLiquidity on hand
$300.0M
$195.0M
Total DebtLower is stronger
$154.3M
Stockholders' EquityBook value
$2.1B
$-98.0M
Total Assets
$2.8B
$1.2B
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCC
HCC
INDV
INDV
Q4 25
$300.0M
$195.0M
Q3 25
$336.3M
$445.0M
Q2 25
$383.3M
$510.0M
Q1 25
$454.9M
$373.0M
Q4 24
$491.5M
Q3 24
$583.2M
Q2 24
$709.0M
Q1 24
$693.9M
Total Debt
HCC
HCC
INDV
INDV
Q4 25
$154.3M
Q3 25
$154.1M
Q2 25
$153.9M
Q1 25
$153.8M
Q4 24
$153.6M
Q3 24
$153.5M
Q2 24
$153.3M
Q1 24
$153.2M
Stockholders' Equity
HCC
HCC
INDV
INDV
Q4 25
$2.1B
$-98.0M
Q3 25
$2.1B
$-207.0M
Q2 25
$2.1B
$-257.0M
Q1 25
$2.1B
$-285.0M
Q4 24
$2.1B
Q3 24
$2.1B
$-310.0M
Q2 24
$2.0B
$-281.0M
Q1 24
$2.0B
Total Assets
HCC
HCC
INDV
INDV
Q4 25
$2.8B
$1.2B
Q3 25
$2.7B
$1.4B
Q2 25
$2.6B
$1.5B
Q1 25
$2.6B
$1.4B
Q4 24
$2.6B
Q3 24
$2.6B
Q2 24
$2.6B
Q1 24
$2.5B
Debt / Equity
HCC
HCC
INDV
INDV
Q4 25
0.07×
Q3 25
0.07×
Q2 25
0.07×
Q1 25
0.07×
Q4 24
0.07×
Q3 24
0.07×
Q2 24
0.07×
Q1 24
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCC
HCC
INDV
INDV
Operating Cash FlowLast quarter
$76.1M
$-221.0M
Free Cash FlowOCF − Capex
$-245.0M
FCF MarginFCF / Revenue
-68.6%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
3.31×
-2.15×
TTM Free Cash FlowTrailing 4 quarters
$-93.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCC
HCC
INDV
INDV
Q4 25
$76.1M
$-221.0M
Q3 25
$104.7M
$-39.0M
Q2 25
$37.5M
$158.0M
Q1 25
$10.9M
$75.0M
Q4 24
$54.2M
Q3 24
$62.2M
$2.0M
Q2 24
$147.0M
$88.0M
Q1 24
$104.1M
Free Cash Flow
HCC
HCC
INDV
INDV
Q4 25
$-245.0M
Q3 25
$-59.0M
Q2 25
$141.0M
Q1 25
$70.0M
Q4 24
Q3 24
$-5.0M
Q2 24
$84.0M
Q1 24
FCF Margin
HCC
HCC
INDV
INDV
Q4 25
-68.6%
Q3 25
-18.8%
Q2 25
46.7%
Q1 25
26.3%
Q4 24
Q3 24
-1.6%
Q2 24
28.1%
Q1 24
Capex Intensity
HCC
HCC
INDV
INDV
Q4 25
6.7%
Q3 25
6.4%
Q2 25
5.6%
Q1 25
1.9%
Q4 24
Q3 24
2.3%
Q2 24
1.3%
Q1 24
Cash Conversion
HCC
HCC
INDV
INDV
Q4 25
3.31×
-2.15×
Q3 25
2.86×
-0.93×
Q2 25
6.70×
8.78×
Q1 25
1.60×
Q4 24
47.68×
Q3 24
1.49×
0.09×
Q2 24
2.08×
Q1 24
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCC
HCC

Mining Segment$373.6M97%
Other$10.4M3%

INDV
INDV

Sublocade$233.0M65%
Sublingual And Other$69.0M19%
Other$49.0M14%
Perseris$6.0M2%

Related Comparisons